文献速递食管胃疾病与幽门螺杆菌胃肠动力与功能性疾病

胃食管反流病患者唾液胃蛋白酶的研究

Studies of salivary pepsin in patients with gastro-oesophageal reflux disease.
PubMed 文献 · Aliment Pharmacol Ther · 2019-01-01

本研究纳入30例确诊胃食管反流病(GERD)患者和20例无症状受试者,进行日间唾液采样及症状触发后60分钟采样,用Peptest和ELISA双盲分析唾液胃蛋白酶。结果显示患者Peptest评分显著低于对照(P<0.005),ELISA无差异,两种方法无相关性,ROC曲线提示二者均不能有效预测GERD。

要点

  • GERD患者Peptest评分显著低于无症状对照(P<0.005)。
  • ELISA法测唾液胃蛋白酶在患者与对照间无差异。
  • ROC曲线提示Peptest和胃蛋白酶均不能有效预测GERD。

核心结论

  • 唾液胃蛋白酶不是诊断GERD的可靠工具。

研究设计与样本

  • 研究纳入30例确诊GERD患者(12例女性,平均年龄49岁,范围20-72岁)和20例无症状受试者(14例女性,平均年龄56岁,范围21-56岁),进行日间唾液采样,并在自我报告反流症状及触发近端反流报警后额外采样60分钟。
  • 唾液样本被分装后分别用Peptest和ELISA分析,每种方法的操作者对样本身份设盲。

主要发现

  • 大多数患者和大多数志愿者中可检测到唾液胃蛋白酶。
  • Peptest评分在患者中显著低于对照(P<0.005)。
  • ELISA评分在患者与对照间无差异。
  • 日间采样时间(P=0.75)或症状后时间(P=0.76)对Peptest读数无影响。
  • Peptest与胃蛋白酶ELISA之间无相关性(P=0.55),Bland-Altman分析提示两种检测方法之间无一致性(P=0.414)。

关键数值与推荐

  • 受试者工作特征曲线提示Peptest(P=0.3328)和胃蛋白酶(P=0.4476)均不能有效预测GERD。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Gastro-oesophageal reflux disease (GERD) is difficult to diagnose without invasive testing. Peptest (RD Biomed, Hull, UK) is a recently marketed diagnostic tool which aims to quantify salivary pepsin as a marker of reflux, providing a rapid alternative to invasive procedures. AIM: To evaluate optimal timing for sampling, and to evaluate the accuracy of Peptest against an independent measure. METHODS: Thirty diagnosed GERD patients (12 female, mean age 49 [range 20-72]) and 20 asymptomatic subjects (14 female, mean age 56 [range 21-56]) were subject to diurnal saliva sampling, with additional samples for 60 minutes following self-reported reflux symptoms and triggering of a proximal reflux alarm. Saliva samples were split and were analysed by both Peptest and ELISA with operators for each blinded to sample identity. RESULTS: Salivary pepsin was detectable in most patients and most volunteers. Peptest scores were significantly lower for patients than controls (P < 0.005). ELISA scores showed no difference between patients and controls. There was no effect of diurnal sampling time (P = 0.75) or time after symptoms (P = 0.76) on Peptest readout. There was no correlation between Peptest and Pepsin ELISA (P = 0.55); Bland-Altman analysis suggested no agreement between the tests (P = 0.414). Receiver-operator curve suggests that neither Peptest (P = 0.3328) nor pepsin (P = 0.4476) is useful for predicting GERD. CONCLUSION: Salivary pepsin is not a reliable tool for the diagnosis of GERD.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Race C, Chowdry J, Russell JM, et al. Studies of salivary pepsin in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2019. PMID: 30977177. doi:10.1111/apt.15138

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。